UNSPSC 51101679: Pretamazium iodide

This classification denotes an antihelminthic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7Z32Z641H2. European Medicines Agency schedules Pretamazium iodide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10031MIG. Pretamazium iodide generally arises in the molecular formula C29H29N2S.I. The term PRETAMAZIUM IODIDE is an International Non-Proprietary Name or INN. Most nations schedule pretamazium iodide under HS 29341000 and SITC 51579.

As of Q4 2014, PRETAMAZIUM IODIDE remains the US FDA Preferred Term for this commodity. Pretamazium iodide bears US NLM identifiers UMLS ID C2347671 and NCI Concept Code C74150. SMILES: I.s1c([n](c(c2ccc(cc2)c2ccccc2)c1)CC)/C=C/c1ccc(N2CCCC2)cc1.

UNSPSC 51101679 Pretamazium iodide is a Commodity code that does not align with the state and local opportunities recently posted under it. The code nominally refers to a specific chemical compound, but the recent solicitations tagged with this code instead cover naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and over-the-counter products—none of which are pretamazium iodide. The mismatch suggests either tagging error in the source data or a broad, non-specific assignment of the code to pharmaceutical and medical supply procurement more generally. State and local governments appear to be using this code (or its parent codes) to solicit health system supplies, emergency medical equipment, and pharmaceutical procurement across counties, cities, state health agencies, and cooperative purchasing alliances, but the recent activity does not reflect the specific chemical commodity the code's name indicates.

Recent opportunities span Florida, Texas, Minnesota, and Oregon through diverse issuing bodies: Seminole County, Florida (an IFB for naloxone and drug deactivation systems, due July 26, 2023); the Texas Health and Human Services Commission (an RFI on direct-to-manufacturer prescriptions, due April 3, 2026); the City of Tampa (an IFB for medical and first aid supplies designated as sheltered for Small Local Business Enterprises, with an estimated contract value of $700,000.00 and a response date of March 13, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance (an RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026). The code shows activity across state health departments, county public health, municipal emergency response, and multi-state cooperative purchasing vehicles, but the specific commodity alignment remains unclear based on available solicitation records.